Nav: Home

Scientists can now measure activity of key cancer cell-survival protein

February 06, 2018

A recent study from the University of Michigan Life Sciences Institute and the University of California, San Francisco, has opened new options to further develop a potential cancer-fighting therapy, clearing an early hurdle in the lengthy drug-discovery process.

The findings, published in the Journal of Biological Chemistry, reveal new ways to measure the activity of a protein that is associated with poor prognosis in cancer patients -- heat shock protein 70, or Hsp70 -- and remove a barrier to developing potential Hsp70-based therapies.

When Hsp70 is present in increased levels, cancer cells are more likely to survive and become resistant to chemotherapeutics. Conversely, when this protein is inhibited in cells, tumor cells are less able to divide, and they eventually die.

Because of its apparent role in cancer cell survival, researchers are interested in developing drugs that block the protein's activity. But these efforts have been hindered by a lack of Hsp70 biomarkers -- measureable surrogates that scientists can evaluate to ensure the compounds they are testing really do what they are supposed to do.

Scientists have found some small molecules that affect Hsp70 in an artificial environment, where they can directly measure Hsp70 activity. To move to the next steps in drug development, researchers need to know how the protein is responding in its natural environment.

"And it's a lot more difficult to measure Hsp70 inhibition in a cell," says lead study author Laura Cesa, Ph.D, a former U-M Program in Chemical Biology graduate student, now at the University of Copenhagen Biotech Research & Innovation Centre.

For this study, the researchers set out to determine whether Hsp70 has its own specific client proteins -- other proteins that can serve as biomarkers for Hsp70.

"This was an interesting question from a basic research standpoint, but it also has exciting therapeutic indications," Cesa explains. "If we can show that inhibiting Hsp70 results in the degradation of its specific client proteins, then those could be used as biomarkers for future development of Hsp70 drugs for cancer therapy."

The team succeeded in identifying client proteins whose levels can be measured and are directly tied to the activity of Hsp70, meaning they can serve as a proxy for measuring Hsp70.

These biomarkers will now enable scientists to take the small molecules that inhibit Hsp70 in artificial environments and begin testing ways to develop them into actual cancer therapeutics.

The significance of these findings led the study to be chosen as the JBC Editors' Pick for the February 16 issue. This honor is reserved for the top 2 percent of the more than 6,600 papers published in the journal each year, in terms of the overall importance of the research.
-end-
The research was supported by the National Institutes of Health and the University of Michigan.

Study authors were Laura C. Cesa, Sharan R. Srinivasan, Eric Tse, Chetali Jain, Erik R. P. Zuiderweg, Daniel R. Southworth and Anna K. Mapp, all of U-M, and Hao Shao and Jason E. Gestwicki of the University of California, San Francisco.

American Society for Biochemistry and Molecular Biology

Related Biomarkers Articles:

Two biomarkers appear to predict course of IPF
Two T cell biomarkers appear to predict the survival trajectory of patients with idiopathic pulmonary fibrosis (IPF), a lung disease that has a varied, but ultimately devastating, impact on patients, according to new research presented at the ATS 2017 International Conference.
Detecting blood clot risk using biomarkers
Researchers at Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) aim to increase survival rates among these patients by identifying new and validating existing biomarkers.
Measuring pain: SLU scientist tests possible biomarkers
A Saint Louis University researcher will leverage her discovery of a pain pathway to determine if either of two key molecules can be used as biomarkers for pain associated with four debilitating health conditions: chemotherapy-induced peripheral neuropathy (CIPN), endometriosis, interstitial cystitis and vulvodynia.
Researchers find autism biomarkers in infancy
By using magnetic resonance imaging (MRI) to study the brains of infants who have older siblings with autism, scientists were able to correctly identify 80 percent of the babies who would be subsequently diagnosed with autism at 2 years of age.
Serum micoRNAs may serve as biomarkers for multiple sclerosis
Serum micoRNAs may serve as biomarkers for multiple sclerosis.
Investigating kidney biomarkers to track lupus
To try to better understand how the disease begins and progresses, researchers at the University of Michigan investigated whether kidney biomarkers would signal lupus progression and signs of complications.
Stanford study identifies new biomarkers for Huntington's disease
Researchers at Stanford University School of Medicine have identified several new biological markers to measure the progression of the inherited neurodegenerative disorder Huntington's disease.
Biomarkers may help better predict who will have a stroke
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the Aug.
Research team discovers two biomarkers that contribute to spine osteoarthritis
A research team at the Krembil Research Institute has discovered a pair of tissue biomarkers that directly contribute to the harmful joint degeneration associated with spine osteoarthritis.
Discovery of biomarkers for the prognosis of chronic kidney disease
Currently, there is no effective method to predict the prognosis of chronic kidney disease (CKD) patients.

Related Biomarkers Reading:

Biomarkers: The 10 Keys to Prolonging Vitality
by William Evans (Author)

Biomarkers: In Medicine, Drug Discovery, and Environmental Health
by Vishal S. Vaidya (Editor), Joseph V. Bonventre (Editor)

The Biomarker Guide v2 2ed
by K. E. Peters (Author)

Biomarkers in Allergy and Asthma, An Issue of Immunology and Allergy Clinics of North America E-Book (The Clinics: Internal Medicine)
by Elsevier

Biomarkers in Inborn Errors of Metabolism: Clinical Aspects and Laboratory Determination (Clinical Aspects and Laboratory Determination of Biomarkers Series)
by Uttam Garg PhD DABCC FABFT FACB (Author), Laurie D. Smith (Author)

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
by Debmalya Barh (Editor), Angelo Carpi (Editor), Mukesh Verma (Editor), Mehmet Gunduz (Editor)

The Handbook of Biomarkers
by Kewal K. Jain (Author)

Analysis of Biomarker Data: A Practical Guide
by Stephen W. Looney (Author), Joseph L. Hagan (Author)

Biomarkers: 10 Determinants of Aging You Can Control
by William Evans (Author), Irwin Rosenberg (Author)

Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
by Tom Brody PhD (Author)

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".